(Q50615721)

English

Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats.

scientific article published on 5 August 2011

Statements

Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit